By: Economic & Finance Report
Pfizer has announced their Covid-19 study on a medication they are beta testing has come back from their lab studies; with a 95% effective accuracy rate in trial testing.
Pfizer has been working with BioNTech (German based biotechnology company) on developing a Covid-19 vaccine as fast and accurately as possible. Both companies have indicated they have met those objectives. They are seeking to attain emergency clearance from the United States and European Union, to be able to distribute the vaccine as soon as possible. -SB
Image Credit: UsaNews.com